SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?


To: Robert Rose who wrote (95613)3/6/2000 8:18:00 PM
From: H James Morris  Respond to of 164687
 
>NeoRx (Nasdaq:NERX) soared 152.15% (up 33 3/16) to 55 after the
company reported that a single dose of NeoRx's proprietary
Pretarget technology cured human lung, colon and breast cancers
implanted in mice. Other bio-techs had mixed results, with
Nexell Therapeutics (Nasdaq:NEXL) also surging 35.96% (up 4) to
15 1/8, Genentech (NYSE:DNA) losing 8.29% (down 19 7/16) to 215
1/16, Human Genome Sciences (Nasdaq:HGSI) dropping 8.48% (down
18 5/16) to 197 11/16, and Gene Logic (Nasdaq:GLGC) falling
9.99% (down 14 7/16) to 130 1/16.